Document:

EX-10.21

 Exhibit 10.21 

Option No.________ 
 ATAI LIFE
SCIENCES AG 
 Stock Option Grant Notice 

Stock Option Grant under the Company’s 

2020 Employee, Director and Consultant Equity Incentive Plan 
  

					
	1.	  	Name and Address of Participant:	  	  

		  		  	  

		  		  	  

			
	2.	  	Date of Option Grant:	  	  

			
	3.	  	Type of Grant (ISO or Non-Qualified) 1:	  	  

			
	4.	  	Maximum Number of Shares for which this Option is exercisable:	  	  

			
	5.	  	Exercise (purchase) price per Share:	  	  

			
	6.	  	Option Expiration Date:	  	  

			
	7.	  	Vesting Start Date2:	  	  

		
	8.	  	Vesting Schedule: This Option shall become exercisable (and the Shares issued upon exercise shall be vested) as follows provided the Participant is an Employee, director or Consultant of the Company or of an Affiliate on
the applicable vesting date:

  

			
	On the first anniversary of the Vesting Start Date	  	up to 25% Shares
		
	Monthly thereafter on the first calendar day of the next month following the first anniversary of the Vesting Start Date for 36 months	  	an additional 2.083% of the Maximum Number of Ordinary Shares per month provided that the number of Ordinary Shares vesting on each date shall be rounded down to the nearest whole number, whilst the number of Ordinary Shares vesting
on the final date shall be the remaining unvested balance of the Shares

 Notwithstanding the foregoing, this Option may not be exercised prior to the first to occur of a (i) Change of Control
(as defined in the Plan) or (ii) the Company’s initial public offering of Common Stock [issued pursuant to a registration statement declared effective under the United States Securities Act of 1933, as amended] or initial
public offering at another renowned stock exchange, each such initial public offering either of the Company directly or 
  

1 ISOs may only be granted to US employees. See Section 6 of the Plan for other rules regarding ISOs.

 2 This date is only necessary if a company has decided to trigger vesting from a date that is
different from the date of option grant such as a hire date and is to be used as a point of reference for future vesting only. 

  
  

 

 indirectly by way of listing of the Company’s parent company (each of (i) and (ii) a
“Liquidity Event”) and this Option shall be cancelled in its entirety if the Participant is no longer an Employee, Director or Consultant of the Company or of an Affiliate on the date of the Liquidity Event. 

Additionally, in the event of a Change of Control (as defined in the Plan), while the Participant is an Employee, Director or Consultant of the Company or an
Affiliate, all of the Shares which remain unvested as of the time of the Change of Control shall accelerate prior to the Change of Control. 

The foregoing rights are cumulative and are subject to the other terms and conditions of this Agreement and the Plan. 

The Company and the Participant acknowledge receipt of this Stock Option Grant Notice and agree to the terms of the Stock Option Agreement
(including its Exhibits) attached hereto and incorporated by reference herein, the Company’s 2020 Employee, Director and Consultant Equity Incentive Plan and the terms of this Option Grant as set forth above. 

 

									
		 		 	ATAI Life Sciences AG
				
	  
	 		 	By:	 	  

	Place, Date	 		 		 	Name:	 	  

		 		 		 	Title:	 	  

				
	  
	 		 		 	  

	Place, Date	 		 		 	Participant

  
 2 

 
  

 ATAI LIFE SCIENCES AG 

STOCK OPTION AGREEMENT- INCORPORATED TERMS AND CONDITIONS 

AGREEMENT made as of the date of grant set forth in the Stock Option Grant Notice by and between ATAI Life Sciences AG, a German stock
corporation and any successor corporation under the terms of the Plan (the “Company”), and the individual whose name appears on the Stock Option Grant Notice (the “Participant”). 

WHEREAS, the Company desires to grant to the Participant an Option to purchase shares of its Common Stock, under and for the purposes set
forth in the Company’s 2020 Employee, Director and Consultant Equity Incentive Plan (the “Plan”); 
 WHEREAS, the Company and
the Participant understand and agree that any terms used and not defined herein have the same meanings as in the Plan; and 
 WHEREAS, the
Company and the Participant each intend that the Option granted herein shall be of the type set forth in the Stock Option Grant Notice. 

NOW, THEREFORE, in consideration of the mutual covenants hereinafter set forth and for other good and valuable consideration, the parties
hereto agree as follows: 
 1. GRANT OF OPTION. 

The Company hereby grants to the Participant the right and option to purchase all or any part of an aggregate of the number of Shares set forth
in the Stock Option Grant Notice, on the terms and conditions and subject to all the limitations set forth herein and in the Plan, which is incorporated herein by reference, and subject to applicable securities laws. The Participant acknowledges
receipt of a copy of the Plan. 
 2. EXERCISE PRICE. 

The exercise price of the Shares covered by the Option shall be the amount per Share set forth in the Stock Option Grant Notice, subject to
adjustment, as provided in the Plan, in the event of a stock split, reverse stock split or other events affecting the holders of Shares after the date hereof (the “Exercise Price”). Payment shall be made in accordance with Paragraph 9 of
the Plan. 
 3. EXERCISABILITY OF OPTION. 

Subject to the terms and conditions set forth in this Agreement and the Plan, the Option granted hereby shall become vested and exercisable as
set forth in the Stock Option Grant Notice and is subject to the other terms and conditions of this Agreement and the Plan. 

  
  

 

 4. TERM OF OPTION. 

This Option shall terminate on the Option Expiration Date as specified in the Stock Option Grant Notice and, if this Option is designated in
the Stock Option Grant Notice as 
 an ISO and the Participant owns as of the date hereof more than 10% of the total combined voting power of all classes of
capital stock of the Company or an Affiliate, such date may not be more than five3 years from the date of this Agreement, but shall be subject to earlier termination as provided herein or in the
Plan. 
 If the Participant ceases to be an Employee, Director or Consultant of the Company or of an Affiliate for any reason other than the
death or Disability of the Participant, or termination of the Participant for Cause (the “Termination Date”), the Option to the extent then vested and exercisable pursuant to Section 3 hereof as of the Termination Date, and not
previously terminated in accordance with this Agreement, may be exercised within three (3)4 months after the Termination Date, or on or prior to the Option Expiration Date as specified in
the Stock Option Grant Notice, whichever is earlier, but may not be exercised thereafter except as set forth below. In such event, the unvested portion of the Option shall not be exercisable and shall expire and be cancelled on the Termination Date.

 If this Option is designated in the Stock Option Grant Notice as an ISO and the Participant ceases to be an Employee of the Company or of
an Affiliate but continues after termination of employment to provide service to the Company or an Affiliate as a Director or Consultant, this Option shall continue to vest in accordance with Section 3 above as if this Option had not terminated
until the Participant is no longer providing services to the Company. In such case, this Option shall automatically convert and be deemed a Non-Qualified Option as of the date that is three (3) months
from termination of the Participant’s employment and this Option shall continue on the same terms and conditions set forth herein until such Participant is no longer providing service to the Company or an Affiliate. 

Notwithstanding the foregoing, in the event of the Participant’s death within three (3) months after the Termination Date, the
Participant’s Survivors may exercise the Option within one (1) year after the Termination Date, but in no event after the Option Expiration Date as specified in the Stock Option Grant Notice, and this Option shall thereupon terminate. 

In the event the Participant’s service is terminated by the Company or an Affiliate for Cause, the Participant’s right to exercise
any unexercised portion of this Option even if vested shall cease immediately as of the time the Participant is notified his or her service is terminated for Cause, and this Option shall thereupon terminate. Notwithstanding anything herein to the
contrary, if subsequent to the Participant’s termination, but prior to the exercise of the Option, the Administrator determines that, either prior or subsequent to the Participant’s termination, the Participant engaged in conduct which
would constitute Cause, then the Participant shall immediately cease to have any right to exercise the Option and this Option shall thereupon terminate. 

In the event of the Disability of the Participant while an Employee, Director or Consultant of the Company or of an Affiliate, as determined
in accordance with the Plan, the Option shall be exercisable within one (1) year after the Participant’s termination of service due 
  

 
 3 Under the ISO rules, five years is the maximum term for an ISO grant to a greater than 10% stockholder. 

4 Three months is the maximum time period for an ISO. If the time period is longer, any option exercised
more than three months after the individual ceases to be an Employee of the company shall be deemed pursuant to the Code to be a non-qualified stock option. 

  
 2 

 
  

 to Disability or, if earlier, on or prior to the Option Expiration Date as specified in the Stock Option
Grant Notice. In such event, the Option shall be fully vested and exercisable. 
 In the event of the death of the Participant while an
Employee, Director or Consultant of the Company or of an Affiliate, the Option shall be exercisable by the Participant’s Survivors within one (1) year after the date of death of the Participant or, if earlier, on or prior to the Option
Expiration Date as specified in the Stock Option Grant Notice. In such event, the Option shall be fully vested and exercisable. 
 5.
METHOD OF EXERCISING OPTION. 
 Subject to the terms and conditions of this Agreement, the Option may be exercised by notice in text
form (sec. 126b of the German Civil Code) to the Company or its designee, in substantially the form of Exhibit A attached hereto (or in such other form acceptable to the Company, which may include electronic notice) (“Notice of
Exercise”). Such notice shall state the number of Shares with respect to which the Option is being exercised and shall be signed by the person exercising the Option (which signature may be provided electronically in a form acceptable to the
Company). Payment of the Exercise Price for such Shares shall be made in accordance with Paragraph 9 of the Plan. The Company shall deliver such Shares as soon as practicable after the notice shall be received, provided, however, that the Company
may delay issuance of such Shares (i) until completion of any action or obtaining of any consent, which the Company deems necessary under any applicable law (including, without limitation, foreign securities laws, United States state securities
or “blue sky” laws) and (ii) in order to minimize the cost and effort of the issuance and delivery of the Shares (e.g. by combining several deliveries of shares), but only for a reasonable time, which may not exceed a period of three
months. The Shares as to which the Option shall have been so exercised shall be delivered as provided above to or upon the order of the person exercising the Option. In the event the Option shall be exercised, pursuant to Section 4 hereof, by
any person other than the Participant, such notice shall be accompanied by appropriate proof of the right of such person to exercise the Option. All Shares that shall be purchased upon the exercise of the Option as provided herein shall be fully
paid and nonassessable. 
 6. PARTIAL EXERCISE. 

Exercise of this Option to the extent above stated may be made in part at any time and from time to time within the above limits, except that
no fractional share shall be issued pursuant to this Option. 
 7. NON-ASSIGNABILITY. 

The Option shall not be transferable by the Participant otherwise than by will or by the laws of descent and distribution. In relation to U.S.
Taxpayers, if this Option is a Non-Qualified Option then it may also be transferred pursuant to a qualified domestic relations order as defined by the U.S. Code or Title I of the U.S. Employee Retirement
Income Security Act or the rules thereunder. Except as provided above in this paragraph, the Option shall be exercisable, during the Participant’s lifetime, only by the Participant (or, in the event of legal incapacity or incompetency, by the
Participant’s guardian or representative) and shall not be 

  
 3 

 
  

 assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be
subject to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition of the Option or of any rights granted hereunder contrary to the provisions of this Section 7, or the levy of
any attachment or similar process upon the Option shall be null and void. 
 8. NO RIGHTS AS STOCKHOLDER UNTIL EXERCISE. 

The Participant shall have no rights as a stockholder in the Company with respect to Shares subject to this Agreement until issuance of the
Shares as set forth in this Agreement and tender of the purchase price for the Shares being purchased. Except as is expressly provided in the Plan with respect to certain changes in the capitalization of the Company, no adjustment shall be made for
dividends or similar rights for which the record date is prior to the date of such registration. 
 9. ADJUSTMENTS. 

The Plan contains provisions covering the treatment of Options in a number of contingencies such as stock splits and mergers. For the avoidance
of doubt, provisions in the Plan for adjustment with respect to stock subject to Options and the related provisions with respect to successors to the business of the Company are hereby made applicable hereunder and are incorporated herein by
reference. 
 10. TAXES; USE OF PROFESSIONAL ADVISORS; ADVICE MADE BY THE COMPANY; DISCLAIMER OF LIABILITY. 

The Participant acknowledges and agrees that (i) any income or other taxes due from the Participant with respect to this Option or the
Shares issuable upon exercise of this Option shall be the Participant’s responsibility to the extent permitted by applicable law; (ii) the Participant was free to use professional advisors of his or her choice in connection with the
execution of this Agreement, has received advice from his or her professional advisors in connection with the execution of this Agreement, understands its meaning and import, and is entering into this Agreement freely and without coercion or duress;
(iii) the Participant has not received and is not relying upon any advice, representations or assurances made by or on behalf of the Company or any Affiliate or any Employee of or legal counsel to the Company or any Affiliate regarding any tax
or other effects or implications of the Option, the Shares or other matters contemplated by this Agreement and (iv) to the extent permitted by applicable law and except for liability of the Company for intend or gross negligence, neither the
Administrator, the Company, its Affiliates, nor any of its officers or directors, shall be held liable for any applicable costs, taxes, or penalties associated with the Option if, in fact, the Internal Revenue Service were to determine that the
Option constitutes deferred compensation under Section 409A of the U.S. Code. 
 If this Option is designated in the Stock Option Grant
Notice as a Non-Qualified Option or if the Option is an ISO and is converted into a Non-Qualified Option and such Non-Qualified
Option is exercised, the Participant agrees that the Company, or any Affiliate of the Company which employs or employed the Participant, may withhold from the Participant’s 

  
 4 

 
  

 remuneration, if any, up to the maximum statutory amount of foreign, United States federal, state and local
withholding taxes attributable to such amount that is considered compensation includable in such person’s gross income. At the Company’s discretion, the amount required to be withheld may be withheld in cash from such remuneration, or in
kind from the Shares otherwise deliverable to the Participant on exercise of the Option. The Participant further agrees that, if the Company, or any Affiliate of the Company which employs or employed the Participant, does not withhold an amount from
the Participant’s remuneration sufficient to satisfy the Company’s income tax withholding obligation, the Participant will reimburse the Company, or any Affiliate of the Company which employs or employed the Participant, on demand, in
cash, for the amount under-withheld. 
 11. PURCHASE FOR INVESTMENT. 

Unless the offering and sale of the Shares to be issued upon the particular exercise of the Option shall have been effectively registered under
the U.S. Securities Act of 1933, as now in force or hereafter amended (the “Securities Act”), the Company shall be under no obligation to issue the Shares covered by such exercise unless the Company has determined that such exercise and
issuance would be exempt from the registration requirements of the Securities Act and until the following conditions have been, to the extent permitted under applicable law, fulfilled: 

 

	 	(a)	 The person(s) who exercise the Option shall warrant to the Company, at the time of such exercise, that such
person(s) are acquiring such Shares for their own respective accounts, for investment, and not with a view to, or for sale in connection with, the distribution of any such Shares, in which event the person(s) acquiring such Shares shall be bound by
the provisions of the following legend which shall be endorsed upon any certificate(s) evidencing the Shares issued pursuant to such exercise: 

“The shares represented by this certificate have been taken for investment and they may not be sold or otherwise transferred by any
person, including a pledgee, unless (1) either (a) a Registration Statement with respect to such shares shall be effective under the United States Securities Act of 1933, as amended, or (b) the Company shall have received an opinion of
legal counsel satisfactory to it that an exemption from registration under such Act is then available, and (2) there shall have been compliance with all applicable United States state securities laws;” and 

 

	 	(b)	 If the Company so requires, the Company shall have received an opinion of its legal counsel that the Shares may
be issued upon such particular exercise in compliance with the Securities Act without registration thereunder. Without limiting the generality of the foregoing, the Company may delay issuance of the Shares (i) until completion of any action or
obtaining of any consent, which the Company deems necessary under any applicable law (including without limitation United States state securities or “blue sky” laws) and (ii) in order to minimize the cost and effort of the issuance
and delivery of the Shares (e.g. by combining several deliveries of shares. 

  
 5 

 
  

 12. RESTRICTIONS ON TRANSFER OF SHARES; REPURCHASE OF SHARES. 

12.1 The Shares acquired by the Participant pursuant to the exercise of the Option granted hereby shall not be transferred by the Participant
except as permitted herein or as required in the Notice of Exercise attached as Exhibit A hereto. 
 12.2 In the event of the
Participant’s termination of service for any reason, the Company shall have, to the extent permitted by applicable law, the option, but not the obligation, to repurchase all or any part of the Shares issued pursuant to this Agreement
(including, without limitation, Shares purchased after termination of service, Disability or death in accordance with Section 4 hereof). In the event the Company does not, upon the termination of service of the Participant (as described above),
exercise its option pursuant to this Section 12.2, the restrictions set forth in the balance of this Agreement shall not thereby lapse, and the Participant for himself or herself, his or her heirs, legatees, executors, administrators and other
successors in interest, agrees that the Shares shall remain subject to such restrictions. The following provisions shall apply to a repurchase under this Section 12.2: 
  

	 	(i)	 The per share repurchase price of the Shares to be sold to the Company upon exercise of its option under this
Section 12.2 shall be equal to the Fair Market Value of each such Share determined in accordance with the Plan as of the date of repurchase provided, however, in the event of a termination by the Company for Cause, the per share repurchase
price of the Shares to be sold to the Company upon exercise of its option under this Section 12.2 shall be equal to the lesser of the Exercise Price and the Fair Market Value on the date of the repurchase. 

 

	 	(ii)	 The Company’s option to repurchase the Participant’s Shares in the event of termination of service
shall be valid for a period of 12 months commencing with the date of such termination of service. 

  

	 	(iii)	 In the event the Company shall be entitled to and shall elect to exercise its option to repurchase the
Participant’s Shares under this Section 12.2, the Company shall notify the Participant, or in case of death, his or her Survivor, in writing of its intent to repurchase the Shares. Such written notice may be mailed or sent by email by the
Company up to and including the last day of the time period provided for in Section 12.2(ii) above for exercise of the Company’s option to repurchase. 

(iv) The notice to the Participant shall specify the address at, and the time and date on, which payment of the repurchase price is to be made
(the “Closing”). The date specified shall not be less than ten (10) days nor more than sixty (60) days from the date of the mailing of the notice, and the Participant or his or her successor in interest with respect to the Shares
shall have no further rights as the owner thereof from and after the date specified in the notice. At the Closing, the repurchase price shall be delivered to the Participant or his or her successor in interest and the Shares being purchased, duly
endorsed for transfer, shall, to the extent that they are not then in the possession of the Company, be delivered to the Company by the Participant or his or her successor in interest. 

  
 6 

 
  

 12.3 To the extent permitted by applicable law, it shall be a condition precedent to the
validity of any sale or other transfer of any Shares by the Participant that the following restrictions be complied with (except as otherwise provided in this Section 12) or in the Notice of Exercise: 

 

	 	(i)	 No Shares owned by the Participant may be sold, pledged or otherwise transferred (including by gift or devise)
to any person or entity, voluntarily, or by operation of law, except in accordance with the terms and conditions hereinafter set forth. 

  

	 	(ii)	 Before selling or otherwise transferring all or part of the Shares, the Participant shall give notice in text
form (sec. 126b of the German Civil Code) of such intention to the Company, which notice shall include the name of the proposed transferee, the proposed purchase price per share, the terms of payment of such purchase price and all other matters
relating to such sale or transfer and shall be accompanied by a copy of the binding written agreement of the proposed transferee to purchase the Shares of the Participant. Such notice shall constitute a binding offer by the Participant to sell to
the Company such number of the Shares then held by the Participant as are proposed to be sold in the notice at the monetary price per share designated in such notice, payable on the terms offered to the Participant by the proposed transferee
(provided, however, that the Company shall not be required to meet any non-monetary terms of the proposed transfer, including, without limitation, delivery of other securities in exchange for the Shares
proposed to be sold). The Company shall give written notice to the Participant as to whether such offer has been accepted in whole by the Company within sixty (60) days after its receipt of notice from the Participant. The Company may only
accept such offer in whole and may not accept such offer in part. Such acceptance notice shall fix a time, location and date for the Closing on such purchase (“Closing Date”) which shall not be less than ten (10) nor more than sixty
(60) days after the giving of the acceptance notice, provided, however, if any of the Shares to be sold pursuant to this Section 12.3 have been held by the Participant for less than six (6) months, then the Closing Date may be
extended by the Company until no more than ten (10) days after such Shares have been held by the Participant for six (6) months if required under applicable accounting rules in effect at the time. The place for such Closing shall be at the
Company’s principal office. At such Closing, the Participant shall accept payment as set forth herein and shall deliver to the Company in exchange therefor certificates for the number of Shares stated in the notice accompanied by duly executed
instruments of transfer. 

  
 7 

 
  

	 	(iii)	 If the Company shall fail to accept any such offer, the Participant shall be free to sell all, but not less
than all, of the Shares set forth in his or her notice to the designated transferee at the price and terms designated in the Participant’s notice, provided that (i) such sale is consummated within six (6) months after the giving of notice
by the Participant to the Company as aforesaid, and (ii) the transferee first agrees in text form (sec. 126b of the German Civil Code) to be bound by the provisions of this Section 12 so that such transferee (and all subsequent
transferees) shall thereafter only be permitted to sell or transfer the Shares in accordance with the terms hereof, and the Company’s right of repurchase set forth in Section 12.2 above shall continue in accordance with its terms. After
the expiration of such six (6) months, the provisions of this Section 12.3 shall again apply with respect to any proposed voluntary transfer of the Participant’s Shares. 

 

	 	(iv)	 The restrictions on transfer contained in this Section 12.3 shall not apply to (a) transfers by the
Participant to his or her spouse or children or to a trust for the benefit of his or her spouse or children, (b) transfers by the Participant to his or her guardian or conservator, and (c) transfers by the Participant, in the event of his
or her death, to his or her executor(s) or administrator(s) or to trustee(s) under his or her will (collectively, “Permitted Transferees”); provided however, that in any such event the Shares so transferred in the hands of each such
Permitted Transferee shall remain subject to this Agreement, and each such Permitted Transferee shall so acknowledge in text form (sec. 126b of the German Civil Code) as a condition precedent to the effectiveness of such transfer.

  

	 	(v)	 The provisions of this Section 12.3 may be waived by the Company. Any such waiver may be unconditional or
based upon such conditions as the Company may impose. 

 12.4 To the extent permitted by applicable law, in the event that
the Participant or his or her successor in interest fails to deliver the Shares to be repurchased by the Company under this Agreement, the Company may elect (a) to establish a segregated account in the amount of the repurchase price, such
account to be turned over to the Participant or his or her successor in interest upon delivery of such Shares, and (b) immediately to take such action as is appropriate to transfer record title of such Shares from the Participant to the Company
and to treat the Participant and such Shares in all respects as if delivery of such Shares had been made as required by this Agreement. The Participant hereby irrevocably grants the Company a power of attorney which shall be coupled with an interest
for the purpose of effectuating the preceding sentence. 
 12.5 To the extent permitted by applicable law, in the event that (i) the
Management Board and (ii) the holders of a majority of the then outstanding shares of Common Stock approve a Sale of the Company (as defined below), specifying that this Section 12.5 shall apply then the 

  
 8 

 
  

 Participant hereby agrees as follows with respect to the Shares and any other equity securities of the
Company which the Participant holds or otherwise exercises dispositive power (the “Drag Along Shares”): 
  

	 	(i)	 in the event such Sale of the Company requires the approval of stockholders, (1) if the matter is to be
brought to a vote at a stockholder meeting, after receiving proper notice of any meeting of stockholders of the Company to vote on the approval of a Sale of the Company, to be present, in person or by proxy, as a holder of Shares, at all such
meetings and be counted for the purposes of determining the presence of a quorum at such meetings; and (2) to vote (in person, by proxy or by action by written consent, as applicable) all Shares in favor of such Sale of the Company and in
opposition of any and all other proposals that could reasonably be expected to delay or impair the ability of the Company to consummate such Sale of the Company; 

 

	 	(ii)	 to refrain from exercising any dissenters’ rights or rights of appraisal under applicable law at any time
with respect to such Sale of the Company; and 

  

	 	(iii)	 to sell to such third party on the terms offered by such third party the Drag Along Shares, or if the Approved
Sale involves less than all of the outstanding capital stock of the Company, the Participant’s pro rata share of the Drag Along Shares, and to execute and deliver all related documentation and take such other action in support of the Sale of
the Company as shall reasonably be requested by the Company. 

 As used herein, the following terms shall have the following respective
meanings: 
 “Fully Diluted Common Shares” means, as of any calculation date, all shares of the Common Stock of the Company then
outstanding, determined on an as-converted basis (and including, for this purpose, any and all shares of Common Stock issued or issuable upon conversion of the Company’s convertible preferred stock, but
specifically excluding, for this purpose, any then outstanding options and warrants). 
 “Sale of the Company” means: 

 

	 	(i)	 a merger or consolidation in which (A) the Company is a constituent party or (B) a subsidiary of the
Company is a constituent party and the Company issues shares of its capital stock pursuant to such merger or consolidation, except any such merger or consolidation involving the Company or a subsidiary in which the shares of capital stock of the
Company outstanding immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by
voting power, of the capital stock of (1) the surviving or resulting corporation or (2) if the surviving or 

  
 9 

 
  

 resulting corporation is a wholly owned subsidiary of another corporation immediately
following such merger or consolidation, the parent corporation of such surviving or resulting corporation (provided that, for the purpose of this clause (i) all shares of Common Stock issuable upon exercise of options or warrants outstanding
immediately prior to such merger or consolidation or upon conversion of convertible securities immediately prior to such merger or consolidation shall be deemed to be outstanding immediately prior to such merger or consolidation and, if applicable,
converted or exchanged in such merger or consolidation on the same terms as the actual outstanding shares of Common Stock are converted or exchanged); 
  

	 	(ii)	 the sale, lease, transfer, exclusive license, or other disposition, in a single transaction or series of
related transactions, by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger or otherwise) of one or more
subsidiaries of the Company if substantially all of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition is to a
wholly owned subsidiary of the Company; or 

  

	 	(iii)	 any transaction or series of related transactions to which the Company is a party in which in excess of fifty
percent (50%) of the Company’s voting power is transferred such that the stockholders of the Company immediately prior to the transaction or series of related transactions do not own a majority of the voting power of the surviving or acquiring
entity following such transaction or series of transactions; other than any transaction or series of transactions principally for bona fide equity financing purposes in which cash is received by the Company or any successor or indebtedness of the
Company is cancelled or converted or a combination thereof. 

 12.6 If the Company shall pay a stock dividend or declare a
stock split on or with respect to any of its Common Stock, or otherwise distribute securities of the Company to the holders of its Common Stock, the number of shares of stock or other securities of the Company issued with respect to the shares then
subject to the restrictions contained in this Agreement shall be added to the Shares subject to the Company’s rights to repurchase pursuant to this Agreement. If the Company shall distribute to its stockholders shares of stock of another
corporation or equity in another entity, the shares of stock of such other corporation or equity in such other entity, distributed with respect to the Shares then subject to the restrictions contained in this Agreement, shall be added to the Shares
subject to the Company’s rights to repurchase pursuant to this Agreement. 

  
 10 

 
  

 12.7 If the outstanding shares of Common Stock of the Company shall be subdivided into a
greater number of shares or combined into a smaller number of shares, or in the event of a reclassification of the outstanding shares of Common Stock of the Company, or if the Company 

shall be a party to a merger, consolidation or capital reorganization, there shall be substituted for the Shares then subject to the restrictions contained in
this Agreement such amount and kind of securities as are issued in such subdivision, combination, reclassification, merger, consolidation or capital reorganization in respect of the Shares subject immediately prior thereto to the Company’s
rights to repurchase pursuant to this Agreement. 
 12.8 The Company shall not be required to transfer any Shares on its books which shall
have been sold, assigned or otherwise transferred in violation of this Agreement, or to treat as owner of such Shares, or to accord the right to vote as such owner or to pay dividends to, any person or organization to which any such Shares shall
have been so sold, assigned or otherwise transferred, in violation of this Agreement. 
 12.9 The provisions of Sections 12.1, 12.2 and 12.3
shall terminate upon the effective date of the registration of the Shares pursuant to the United States Securities Exchange Act of 1934,or as otherwise approved by the Administrator. 

12.10 To the extent permitted by applicable law, the Participant agrees that, in the event the Company proposes to offer for sale to the public
any of its equity securities and such Participant is requested by the Company and any underwriter engaged by the Company in connection with such offering to sign an agreement restricting the sale or other transfer of Shares, then it will promptly
sign such agreement and will not transfer, whether in privately negotiated transactions or to the public in open market transactions or otherwise, any Shares or other securities of the Company held by him or her during such period as is determined
by the Company and the underwriters, not to exceed 180 days following the closing of the offering, plus such additional period of time as may be required to comply with FINRA Rules or similar rules promulgated by another regulatory authority (such
period, the “Lock-Up Period”). Such agreement shall be in writing and in form and substance reasonably satisfactory to the Company and such underwriter and pursuant to customary and prevailing terms
and conditions. Notwithstanding whether the Participant has signed such an agreement, the Company may impose stop-transfer instructions with respect to the Shares or other securities of the Company subject to the foregoing restrictions until the end
of the Lock-Up Period. 
 12.11 The Participant acknowledges and agrees that, without prejudice to
(any) rights of the Participant as a shareholder of the Company (especially in accordance with sec. 131 of the German Stock Corporation Act), neither the Company, its shareholders nor its directors and officers, has any duty or obligation to
disclose to the Participant any material information regarding the business of the Company or affecting the value of the Shares before, at the time of, or following a termination of the service of the Participant by the Company or any Affiliate,
including, without limitation, any information concerning plans for the Company to make a public offering of its securities or to be acquired by or merged with or into another firm or entity. 

13. NO OBLIGATION TO MAINTAIN RELATIONSHIP; NO RIGHT AND NO PREDJUDICE TO RECEIVE FUTURE GRANTS OF OPTIONS; OPTIONS AS EXTRAORDENARY ITEM OF
COMPENSATION. 

  
 11 

 
  

 The Participant acknowledges that: (i) the Company is not by the Plan or this Option
Agreement obligated to continue the Participant as an Employee, Director or Consultant of the Company or an Affiliate; (ii) the Plan is discretionary in nature and may be suspended or terminated by the Company at any time; (iii) the grant
of the Option is a one-time benefit which does not create any contractual or other right to receive future grants of options, or benefits in lieu of options; (iv) all determinations with respect to any
such future grants, including, but not limited to, the times when options shall be granted, the number of shares subject to each option, the option price, and the time or times when each option shall be exercisable, will be at the sole discretion of
the Company; (v) the Participant’s participation in the Plan is voluntary; (vi) the value of the Option is an extraordinary item of compensation which is outside the scope of the Participant’s employment or consulting contract,
if any; and (vii) the Option is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar
payments. 
 14. IF OPTION IS INTENDED TO BE AN ISO. 

If this Option is designated in the Stock Option Grant Notice as an ISO so that the Participant (or the Participant’s Survivors) may
qualify for the favorable tax treatment provided to holders of Options that meet the standards of Section 422 of the U.S. Code then any provision of this Agreement or the Plan which conflicts with the U.S. Code so that this Option would not be
deemed an ISO is, to the extent permitted by applicable law, null and void and any ambiguities shall be resolved so that the Option qualifies as an ISO. The Participant should consult with the Participant’s own tax advisors regarding the tax
effects of the Option and the requirements necessary to obtain favorable tax treatment under Section 422 of the U.S. Code, including, but not limited to, holding period requirements. 

Notwithstanding the foregoing, to the extent that the Option is designated in the Stock Option Grant Notice as an ISO and is not deemed to be
an ISO pursuant to Section 422(d) of the U.S. Code because the aggregate Fair Market Value (determined as of the Date of Option Grant) of any of the Shares with respect to which this ISO is granted becomes exercisable for the first time during
any calendar year in excess of $100,000, the portion of the Option representing such excess value shall be treated as a Non-Qualified Option and the Participant shall be deemed to have taxable income measured
by the difference between the then Fair Market Value of the Shares received upon exercise and the price paid for such Shares pursuant to this Agreement. 

Neither the Company nor any Affiliate shall have any liability to the Participant, or any other party, if the Option (or any part thereof)
that is intended to be an ISO is not an ISO or for any action taken by the Administrator, including without limitation the conversion of an ISO to a Non-Qualified Option; this does not apply in case of
liability of the Company for intent or gross negligence. 
 15. NOTICE TO COMPANY OF DISQUALIFYING DISPOSITION OF AN ISO. 

If this Option is designated in the Stock Option Grant Notice as an ISO then the Participant agrees to notify the Company upon request in text
form (sec. 126b of the German Civil Code) immediately after the Participant makes a Disqualifying Disposition of any of the Shares acquired pursuant to the exercise of the ISO. A Disqualifying Disposition is defined in Section 424(c) of the
U.S. Code and includes any disposition (including any sale) of such Shares 
 before the later of (a) two years after the date the Participant was
granted the ISO or (b) one year after the date the Participant acquired Shares by exercising the ISO, except as otherwise provided in Section 424(c) of the U. S. Code. If the Participant has died before the Shares are sold, these holding
period requirements do not apply and no Disqualifying Disposition can occur thereafter. 

  
 12 

 
  

 16. NOTICES. 

Any notices required or permitted by the terms of this Agreement or the Plan shall be addressed as follows: 

If to the Company: 
 ATAI Life Sciences AG 

Barer Str. 7 
 80333 Munich 

Germany 
 Attention: [____] 

Email: [please complete] 
 If to
the Participant at the address set forth on the Stock Option Grant Notice or such address as the Company may then have in its records for the Participant 

or to such other address or addresses of which notice in the same manner has previously been given. 

17. GOVERNING LAW. 
 This
Agreement shall be governed by and construed in accordance with German Law, applied without regard to conflict of law principles. 
 Place
of jurisdiction shall be the Company’s domicile. 
 18. BENEFIT OF AGREEMENT. 

Subject to the provisions of the Plan and the other provisions hereof, this Agreement shall be for the benefit of and shall be binding upon
the heirs, executors, administrators, successors and assigns of the parties hereto. 
 19. ENTIRE AGREEMENT. 

This Agreement, together with the Plan attached hereto, embodies the entire agreement and understanding between the parties hereto with
respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or agreement not expressly set forth in this
Agreement shall affect or be used to interpret, change or restrict, the express terms and provisions of this Agreement, provided, however, in any event, this Agreement shall be subject to and governed by the Plan. 

  
 13 

 
  

 20. MODIFICATIONS AND AMENDMENTS. 

The terms and provisions of this Agreement may be modified or amended as provided in the Plan; a unilateral modification or amendment by the
Company is only permitted if it is reasonable for the Participant, taking into account the Participant’s interests. 
 21. WAIVERS
AND CONSENTS. 
 Except as provided in the Plan, the terms and provisions of this Agreement may be waived, or consent for the departure
therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or
provisions of this Agreement, whether or not similar. Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent. 

22. MISCELLANIOUS. 

Should any provision of this Agreement, or any provision incorporated into this Agreement in the future, be or become invalid or
unenforceable, the validity or enforceability of the other provisions of this Agreement shall not be affected thereby. The same shall apply if the parties hereto have failed to address a certain matter in this Agreement. The invalid or unenforceable
provision shall be deemed to be substituted by, and the parties hereto shall be deemed to have agreed upon, a suitable and equitable provision which, to the extent legally permitted, comes closest to the provisions set forth in the Plan and the
purpose of the invalid or enforceable provision or to the presumed intent of the parties hereto if they had considered the matter. 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 14 

 
  

 ATAI LIFE SCIENCES AG 

DATA PRIVACY; AUTHORIZATION FOR DATA PROCESSING 

I, 
  

                       
                      
 (Name of
the Participant) 
 hereby 

(i) authorize the Company and each Affiliate, and any agent of the Company or any Affiliate administering the Plan or providing Plan
recordkeeping services, to disclose to the Company or any of its Affiliates such information and data as the Company or any such Affiliate shall request in order to facilitate the grant of options and the administration of the Plan; and 

(ii) to the extent permitted by law waive any data privacy rights I may have with respect to such information; and 

(iii) authorize the Company and each Affiliate to store and transmit such information in electronic form for the purposes set forth in this
Agreement. 
 [Information on the Procession of personal data according to the European data protection regulation (GDPR): In so far as the processing
of personal data is carried out in the context of the activities in the European Union (see sec. 3 GDPR), the Company must inform the Participant about the processing of his/her personal data before giving his/her authorization. The information must
contain at least the information required under sec. 13 and 14 GDPR)] 
  

					
	  
 Place, Date
	 		  	  

Participant

  

  
 15 

 
  

 Exhibit A 

NOTICE OF EXERCISE OF STOCK OPTION 

[Form for Unregistered Shares] 
  

	To:	 ATAI Life Sciences AG 

Ladies and Gentlemen: 
 I hereby exercise my
Stock Option to purchase ___ shares (the “Shares”) of the common stock, with no par value, of ATAI Life Sciences AG, a German stock corporation (the “Company”), at the exercise price of $[_____] per share, pursuant to and subject
to the terms of that certain Stock Option Agreement between the undersigned and the Company dated ______. 
 I am aware that the Shares have
not been registered under the United States Securities Act of 1933, as amended (the “Securities Act”), or any United States state securities laws. I understand that the reliance by the Company on exemptions under the Securities Act is
predicated in part upon the truth and accuracy of the statements by me in this Notice of Exercise. 
 I hereby represent and warrant that
(1) I have been furnished with all information which I deem necessary to evaluate the merits and risks of the purchase of the Shares; (2) I have had the opportunity to ask questions concerning the Shares and the Company and all questions
posed have been answered to my satisfaction; (3) I have been given the opportunity to obtain any additional information I deem necessary to verify the accuracy of any information obtained concerning the Shares and the Company; and (4) I
have such knowledge and experience in financial and business matters that I am able to evaluate the merits and risks of purchasing the Shares and to make an informed investment decision relating thereto. 

I hereby represent and warrant that I am purchasing the Shares for my own personal account for investment and not with a view to the sale or
distribution of all or any part of the Shares. 
 I understand that because the Shares have not been registered under the Securities Act, I
must continue to bear the economic risk of the investment for an indefinite time and the Shares cannot be sold unless the Shares are subsequently registered under applicable United States federal and state securities laws or an exemption from such
registration requirements is available. 
 I agree that I will in no event sell or distribute or otherwise dispose of all or any part of the
Shares unless (1) there is an effective registration statement under the Securities Act and applicable United States state securities laws covering any such transaction involving the Shares or (2) the Company receives an opinion of my
legal counsel (concurred in by legal counsel for the Company) stating that such transaction is exempt from registration or the Company otherwise satisfies itself that such transaction is exempt from registration. 

  
 Exhibit A-1 
  
  

 I consent to the placing of a legend on my certificate for the Shares stating that the
Shares have not been registered and setting forth the restrictions on transfer contemplated hereby and to the placing of a stop transfer order on the books of the Company and with any transfer agents against the Shares until the Shares may be
legally resold or distributed without restriction. 
 I understand that at the present time Rule 144 of the United States Securities and
Exchange Commission (the “SEC”) may not be relied on for the resale or distribution of the Shares by me. I understand that the Company has no obligation to me to register the sale of the Shares with the SEC and has not represented to me
that it will register the sale of the Shares. 
 I understand the terms and restrictions on the right to dispose of the Shares set forth in
the 2020 Employee, Director and Consultant Equity Incentive Plan and the Stock Option Agreement, both of which I have carefully reviewed. I consent to the placing of a legend on my certificate for the Shares referring to such restriction and the
placing of stop transfer orders until the Shares may be transferred in accordance with the terms of such restrictions. 
 I understand
and agree that if a Stockholders Agreement between the Company and certain of its stockholders is in place in relation to such stockholders’ participation in the Company (the “Stockholders Agreement”), and if I am not already a party
to the Stockholders Agreement and if the Company so requests I agree to become a party to such Stockholders Agreement by execution of the Adoption Agreement to such Stockholders Agreement attached hereto. I acknowledge that I have read and
understand the Stockholders Agreement which sets forth certain restrictions and limitations on the Shares, including the ability to transfer or sell them in the future. I further acknowledge and agree that to the extent the terms of Section 12
of the Option Agreement conflict with the Stockholders Agreement, the terms contained in the Stockholders Agreement shall govern. 

Further, I understand and agree that the Company is considering to convert into a Dutch limited liability company (Besloten Vernnootschap,
BV) or other corporation under Dutch law by effecting a share swap and having its stockholders exchange the shares in the Company into shares into a newly incorporated Dutch entity to become the owner of the shares in the Company (“Dutch
Flip”). I agree to convert the Shares into such other instrument issued in course of the Dutch flip on the same terms and conditions as the other stockholder participating in the Dutch Flip and duly execute any related documentation, as the
case may be. 
 I have considered, as applicable, any foreign and/or the United States federal, state and local income tax implications of
the exercise of my Option and the purchase and subsequent sale of the Shares. 
 I am paying the option exercise price for the Shares as
follows: 
  

                       
                                         
                                         
    
 Please issue the Shares (check one): 

☐ to me; or 

  
 Exhibit A-2 
  
  

 ☐ to me and ________________, as joint tenants with right of survivorship 

and mail the certificate to me at the following address: 
  

                          
               

                          
               

                          
               
 My mailing address for shareholder
communications, if different from the address listed above is: 
  

                          
               

                          
               

                          
               
  

	
	Very truly yours,
	
	          

	Participant (signature)
	
	          

	Print Name
	
	          

	Date

 Exhibit A-3EX-10.22

 Exhibit 10.22 

Partnership Agreement 

(Gesellschaftsvertrag) 

of 
 ATAI Life Sciences
HSOP GbR 
 Dated: 21 August 2020 
  

 
 Execution
version 
  
  

 PARTNERS (GESELLSCHAFTER) 

 

	(1)	 Florian Brand, born 4 September 1986, address: Yorckstr. 69, 10965 Berlin (including his legal
successors, if any, hereinafter “Partner Without Asset Share”); 

  

	(2)	 ATAI Life Sciences AG, a German stock corporation registered with the commercial register of the local
court of Munich (Amtsgericht München) under HR B 239 201, business address: Barer Str. 7, 80333 Munich (including its legal successors, if any, hereinafter “Partner With Unallocated Asset Share” or
“Company”); 

 - party no. (2) 

as well as any and all future partners (Gesellschafter) of the partnership upon accession, as Partner(s) With Asset Share, to the
partnership and to this Partnership Agreement in the future, including their legal successors, if any, hereinafter the “Partner(s) With Asset Share” - 

- all of parties no. (1) through no. (2) 

 as well as any and all future partners (Gesellschafter) of the partnership upon accession to the partnership and to this Partnership
Agreement in the future including their legal successors, if any, hereinafter the “Partner(s)” - 

  
 - 2 - 

 TABLE OF CONTENTS 

 

							
	 PARTNERS (Gesellschafter)
	  	 	2	 
		
	 Table of Contents
	  	 	3	 
		
	 List of Annexes
	  	 	4	 
			
	 I.
	 	RECITALS	  	 	5	 
			
	 1.
	 	Introduction	  	 	5	 
			
	 2.
	 	Definitions	  	 	8	 
			
	 II.
	 	PARTNERSHIP AGREEMENT	  	 	9	 
			
	 3.
	 	Formation of Partnership, form of organization, name, place of business	  	 	9	 
			
	 4.
	 	Business purpose	  	 	9	 
			
	 5.
	 	Business year, duration of the Partnership	  	 	9	 
			
	 6.
	 	Partners, contributions, asset shares	  	 	10	 
			
	 7.
	 	Reverse vesting of participation in the Partnership	  	 	13	 
			
	 8.
	 	Partner Accounts	  	 	17	 
			
	 9.
	 	Management, Representation	  	 	18	 
			
	 10.
	 	Capital Measures at the Company	  	 	20	 
			
	 11.
	 	Listing	  	 	20	 
			
	 12.
	 	Resolutions of the Partners	  	 	21	 
			
	 13.
	 	Confidentiality obligation	  	 	23	 
			
	 14.
	 	Distribution of profits and losses, withdrawals	  	 	23	 
			
	 15.
	 	Disposal of participation in the Partnership	  	 	24	 
			
	 16.
	 	Exclusion of Partners With Asset Share	  	 	24	 
			
	 17.
	 	Death of a Partner	  	 	25	 
			
	 18.
	 	Dissolution	  	 	25	 
			
	 19.
	 	Taxes	  	 	26	 
			
	 20.
	 	Final Provisions	  	 	26	 

  
 - 3 - 

 LIST OF ANNEXES 

 

					
	 Annex 9.1 – Form of power of attorney to Managing Partner
	  	 	18	 
		
	 Annex 9.1.2 – Form of Accession Agreement
	  	 	18	 

  
 - 4 - 

 I. RECITALS 
  

	1.	 Introduction 

  

	1.1	 On or around the date of this Partnership Agreement
(GbR-Gesellschaftsvertrag) (the “Agreement”), the shareholders of the Company resolved (i) to increase the share capital of the Company by EUR 100,000.00 by way of issuing 100,000
new shares with a (notional) nominal value of EUR 1.00 each (the “HSOP Shares”) and (ii) an authorized capital in the amount of EUR 900,000.00 from which up to 900,000 HSOP Shares can be issued, in each case, against
payment of an issue price equal to such HSOP Shares’ (notional) nominal amounts. The HSOP Shares have been/shall be made available for subscription by the Partnership only. The Partnership shall, from time to time, subscribe for and hold the
HSOP Shares in accordance with this Agreement and the Company’s articles of association (Satzung), as amended from time to time, as the case may be (the “Company’s Articles”). 

On or around the date of this Agreement, the Partnership intends to subscribe for 60,008 of the HSOP Shares. 

 

	1.2	 The shareholders’ meeting of the Company agreed that, by way of issuing the HSOP Shares against payment of
their (notional) nominal amounts only, the Partnership shall benefit from the further increase of the economic value of the Company which is accumulated after the date of the adoption of the shareholder resolutions referred to under section 1.1
above (the “Reference Date”, the value of each share in the Company with a (notional) nominal value of EUR 1.00 (for clarification: without considering the HSOP Shares) reflecting the economic value of the Company at the
Reference Date less the (notional) nominal value of EUR 1.00, the “Strike Price”). To that effect, the indirect holders of the HSOP Shares (i.e., the relevant Partners With Asset Share as beneficiaries via the Partnership)
shall, with regard to the HSOP Shares allocated to them benefit from and participate in further proceeds generated from exit transactions and/or liquidity events based on valuations of the Company exceeding the Company’s valuation at the
Reference Date. To this effect, pursuant to the relevant provisions of the Company’s Articles, the HSOP Shares will be considered in the course of distribution of proceeds only secondarily after all other shares in the Company (irrespective of
their class, if any) have received proceeds in an amount that is equal to the Strike Price (the “Second Rank Preference”). 

  

	1.3	 Based on a certain valuation report received by the Company, the Parties assume the Strike Price being EUR
32.00 (in words: Euro thirty-two). 

  

	1.4	 Any HSOP Shares subscribed by the Partnership at any given time, as may be unallocated from time to time,
shall, at the level of the Partnership, be allocated to the Partner With Unallocated Asset Share. Such part of the assets of the Partnership shall be available for re-allocation from the Partner With
Unallocated Asset Share to certain current or future key employees, consultants, directors or advisors of the Company (or their holding companies, respectively) in the future upon accession to the Partnership as

  
 - 5 - 

	 	
further Partners With Asset Share, as the case may be. By way of such re-allocation, the relevant Partners With Asset Share will acquire an (indirect)
shareholding in the Company and thus be awarded with the chance to benefit from the further increase of the economic value of the Company that is generated after the taking effect of the relevant re-allocation
of the relevant HSOP Shares. 

 In accordance with the concept described in Section 1.2 above, in the event of any re-allocation of HSOP Shares at the level of the Partnership from the Partner With Unallocated Asset Share to existing or newly acceded Partners With Asset Share, the relevant Partners With Asset Share shall, at the
level of the Partnership, with regard to such re-allocated HSOP Shares equally benefit from the further increase of the economic value of the Company which is accumulated after the Reference Date. However, in
the event of any re-allocation of HSOP Shares at the level of the Partnership from the Partner With Unallocated Asset Share to existing or newly acceded Partners With Asset Share, the relevant Partners With
Asset Share benefitting from such re-allocation shall pay a compensation to the Partnership per re-allocated HSOP Share with a (notional) nominal value of EUR 1.00
(i) that is equal to the value per share in the Company at the date of the taking effect of the relevant re-allocation of the relevant HSOP Shares less the Strike Price and less the (notional) nominal value of
EUR 1.00, (ii) that shall be deferred until the occurrence of an exit transaction or liquidity event, and (iii) to which, as among the Partners, the Partner With Unallocated Asset Share shall be exclusively entitled as set forth in this
Agreement. 
  

	1.5	 The Partners acknowledge that the Company is considering to convert into a Dutch limited liability company
(Besloten Vernnootschap, BV) or other corporation under Dutch law (the “Dutch HoldCo”) by effecting a share swap and having its stockholders exchange the shares in the Company into shares in a (newly incorporated) Dutch
entity to become the owner of the shares in the Company (the “Dutch Flip”). The Partners agree and will procure that: 

  

	 	1.5.1	 the Partnership participates in the Dutch Flip and contributes the HSOP Shares to the Dutch HoldCo in exchange
for shares in Dutch HoldCo, or such other instrument issued in course of the Dutch Flip, pro rata to the Partnership’s current shareholding in the Company on the same terms and conditions as the other stockholders participating in the Dutch
Flip; 

  

	 	1.5.2	 the Partnership and, if necessary, each of the Partners, execute any related documentation in connection with
the Dutch Flip, as the case may be; and 

  

	 	1.5.3	 the shares in Dutch HoldCo issued to the Partnership as a result of the Dutch Flip shall be treated as HSOP
Shares in accordance with the provisions of this Partnership Agreement. 

 The Partnership will procure that the shares in
Dutch HoldCo issued to the Partnership as a result of the Dutch Flip shall continue to participate in the Company’s increased valuation as from the Reference Date only. 

  
 - 6 - 

	1.6	 The Partners acknowledge that the Company is considering, in particular after the Dutch Flip, a listing and
admission to trading of the shares in the Company (or of any other shares replacing such shares in the Company, including in particular any shares in any successor entity of the Company) on a stock exchange, including an initial public offering of
the shares in the Company, (the “Listing”) 

 In preparation of a Listing, it might prove necessary to
amend the Articles to the effect that the Secondary Rank Preference is abrogated. In case of such abrogation of the Secondary Rank Preference, each Partner With Asset Share shall effect a compensation to the Partnership per HSOP Share allocated to
the relevant Partner With Asset Share (i) that is equal to the Strike Price, (ii) that shall be deferred until the occurrence of a liquidity event, and (iii) to which, as among the Partners, the Partner With Unallocated Asset Share
shall be exclusively entitled as set forth in this Agreement. 
 NOW, THEREFORE, the Parties agree as follows: 

  
 - 7 - 

	2.	 Definitions 

In this Agreement the following words and expressions shall have the meanings ascribed to them in this Agreement. 

 

					
	 DEFINITIONS
	  			
	 Acquisition
	  	 	12	 
	 Affiliate
	  	 	14	 
	 Agreement
	  	 	5	 
	 Bad Leaver Event
	  	 	14	 
	 Cash Compensation Amounts
	  	 	11	 
	 Change of Control
	  	 	12	 
	 Company
	  	 	2	 
	 Company’s Articles
	  	 	5	 
	 Disability
	  	 	15	 
	 Distribution Request
	  	 	21	 
	 Dutch Flip
	  	 	6	 
	 Dutch HoldCo
	  	 	6	 
	 Good Leaver Event
	  	 	15	 
	 HSOP Assets
	  	 	10	 
	 HSOP Shares
	  	 	5	 
	 Liquidity Event
	  	 	12	 
	 Listing
	  	 	7	 
	 Listing Compensation Amount
	  	 	20	 
	 Lock-Up Period
	  	 	13	 
	 Managing Partner
	  	 	18	 
	 Partner Account(s)
	  	 	17	 
	 Partner With Unallocated Asset Share
	  	 	2	 
	 Partner Without Asset Share
	  	 	2	 
	 Partner(s)
	  	 	2	 
	 Partner(s) With Asset Share
	  	 	2	 
	 Partnership
	  	 	9	 
	 Partnership Assets
	  	 	10	 
	 Purpose
	  	 	9	 
	 Re-Allocation Compensation Amount
	  	 	11	 
	 Reference Date
	  	 	5	 
	 Second Rank Preference
	  	 	5	 
	 Strike Price
	  	 	5	 
	 Textform
	  	 	11	 
	 Transfer Date
	  	 	11	 
	 Vested HSOP Assets
	  	 	16	 
	 Vesting Period
	  	 	15	 
	 Vesting Start Date
	  	 	16	 

  

  
 - 8 - 

 II. PARTNERSHIP AGREEMENT 

 

	3.	 Formation of Partnership, form of organization, name, place of business 

 

	3.1	 The Partners hereby form a civil law partnership pursuant to sections 705 et. seqq. German Civil Code
(Gesellschaft bürgerlichen Rechts gemäß §§ 705 ff. BGB) with the Partners as partners (Gesellschafter) (the “Partnership”). 

 

	3.2	 The name of the Partnership shall be 

“ATAI Life Sciences HSOP GbR”. 
  

	3.3	 The Partnership shall be governed by this Agreement. 

 

	3.4	 The place of business of the Partnership shall be in Berlin, Germany. 

 

	3.5	 The address of the Partnership is c/o ATAI Life Sciences AG, Barer Str. 7, 80333 Munich, Germany.

  

	4.	 Business purpose 

The only business purpose of the Partnership shall be the acquisition (including by way of subscription of new shares), holding, administration
and sale or other disposal of shares in the Company, in particular of HSOP Shares (the “Purpose”). 
 The Partnership may
enter into all transactions and take all measures that serve the Purpose directly or indirectly unless an official permission or approval is required. 
  

	5.	 Business year, duration of the Partnership 

 

	5.1	 The business year of the Partnership shall be equal to the calendar year. 

 

	5.2	 Each party hereto may terminate this Agreement in writing with twelve (12) months’ notice to the end
of a calendar year, but in no event with effect to a date prior to 31 December 2035. The right to terminate this Agreement for good cause (aus wichtigem Grund) shall remain unaffected. 

Should a Partner cease to be a partner of the Partnership, the Partnership shall continue to exist among the remaining Partners. The right to
regular termination of the Partnership shall be excluded to the extent legally permissible; the right to termination for good cause (außerordentliche Kündigung) shall remain unaffected. 

  
 - 9 - 

	6.	 Partners, contributions, asset shares 

 

	6.1	 The Partners shall be the partners (Gesellschafter) of the Partnership. 

 

	6.2	 The Partners shall make contributions in cash to the Partnership equal to the (notional) nominal amount of the
HSOP Shares allocated to them indirectly through the Partnership as follows: 

  

					
	 Partner Without Asset Share
	  	 	EUR 60,008.00	 

 The payments shall be due immediately after conclusion of this Agreement. Beyond that, the Partners shall not
be obliged to make any contributions or to make subsequent contributions to the capital of the Partnership unless expressly set forth otherwise herein. 

The Partnership, represented by the Managing Partner, shall use such funds to pay the issue price and to subscribe to the HSOP Shares from the
relevant capital increase of the Company. 
  

	6.3	 The assets of the Partnership (Gesellschaftsvermögen) (the “Partnership
Assets”) consist of the HSOP Shares (the relevant Partnership Assets or any other assets received by the Partnership in exchange for such Partnership Assets, the “HSOP Assets”) and the Cash Compensation Amounts (as defined
below), if any. The Partner Without Asset Share shall not participate in the Partnership Assets (Gesellschafter ohne Kapitalanteil). The Cash Compensation Amounts, if any, shall be exclusively allocated to the Partner With Unallocated Asset
Share. The HSOP Assets shall be allocated among the Partners With Asset Share (including, for clarification purposes, the Partner With Unallocated Asset Share, to whom such HSOP Assets shall be allocated that are not allocated to other Partners With
Assets Share from time to time, as the case may be) as follows, provided, that such allocation may be adjusted from time to time in accordance with the terms and provisions of this Agreement: 

 

													
	 Partner
	  	Allocation of HSOP Assets among
Partners	 
	  	HSOP Shares allocated
to the Partners	 	  	Percentage
of HSOP
Assets	 
	  	Absolute
amount	 	  	Consecutive
numbers	 
	 Partner With Unallocated Asset Share
	  	 	60,008	 	  	 	n/a	 	  	 	100.00	 
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 Total
	  	 	60,008	 	  				  	 	100.00	% 
		  	  
	  
	 	  				  	  
	  
	 

 The Managing Partner (as defined below) is hereby authorized and instructed by all of the Partners to update,
from time to time, the above table to reflect the allocation of HSOP Assets among the partners, including any (future) Partners With Asset Share; in particular, but without limitation, upon implementation of any of the measures referred

  
 - 10 

 
to in section 9.1.2 and/or section 7.5 and/or following distributions to the Partners. If the Managing Partner makes any changes pursuant to the preceding sentence, the Managing Partner
shall send an updated version of the table to the other Partners at least in Textform pursuant to section 126 b German Civil Code (BGB) (the “Textform”). 

It is herewith clarified that the Partner With Unallocated Asset Share shall remain a Partner also in case the amount of the HSOP Shares
allocated to the Partner With Unallocated Asset Share falls to zero. 
 In the event that the HSOP Shares are replaced by other securities,
in particular, but without limitation, in case of a Dutch Flip in preparation of a Listing, the principles set forth in this Agreement shall apply mutatis mutandis to the relevant securities replacing the HSOP Shares. 

 

	6.4	 In the event of a transfer of all or part of the HSOP Assets allocated to the Partner With Unallocated Asset
Share to existing or newly acceded (other) Partners With Asset Share, the following shall apply: 

  

	 	6.4.1	 The Partner With Unallocated Asset Share shall transfer the relevant part or all of the HSOP Assets then
allocated to the Partner With Unallocated Asset Share (i.e. indirect transfer of an absolute number of HSOP Shares then allocated to the Partner With Unallocated Asset Share) to the relevant new or existing (other) Partner With Asset Share (i.e. the
relevant current or future key employee, consultant, director or advisor of the Company (or his/her holding company, respectively)). Such transferred HSOP Assets shall be re-allocated from the Partner With
Unallocated Asset Share to the relevant (other) Partner With Asset Share. 

  

	 	6.4.2	 From the date of the taking effect of the relevant (indirect) transfer and
re-allocation of the relevant HSOP Assets (“Transfer Date”), the relevant (other) Partner With Asset Share shall be the sole and ultimate beneficiary of the relevant transferred HSOP Assets
(i.e. indirectly the relevant absolute number of HSOP Shares then allocated to such (other) Partner With Asset Share). 

  

	 	6.4.3	 The (other) Partner With Asset Share shall make a contribution payment to the Partnership to which the
provisions of section 6.2 shall apply mutatis mutandis and the Euro amount of which equals the absolute amount of the relevant transferred HSOP Assets. 

  

	 	6.4.4	 The (other) Partner With Asset Share shall make a further payment to the Partnership to compensate the increase
in value of the relevant transferred HSOP Assets having occurred between the Reference Date and the relevant Transfer Date (the “Re-Allocation Compensation Amount” and together with the
Listing Compensation Amount (as defined below), the “Cash Compensation Amounts”). The Re-Allocation Compensation Amount shall for each HSOP Share with a (notional) nominal value of
EUR 1.00 that is (indirectly) re-allocated from the Partner With Unallocated Asset Share to the (other) Partner With Asset Share be an amount equal to the fair market value

  
 - 11 - 

	 	
(gemeiner Wert) per such share in the Company that is not a HSOP Share at the relevant Transfer Date minus the Strike Price and minus the (notional) nominal value of EUR 1.00. The Re-Allocation Compensation Amount shall not be payable immediately but shall be deferred with bearing interest of 2 % p.a. (in words: 2 per cent per annum) until the occurrence of one of the following
events (each a “Liquidity Event”): 

  

	 	a)	 A Change of Control (as defined below), provided that (i) at least all of the HSOP Shares (or any HSOP
Assets replacing such shares) allocated to the Partners With Asset Share (provided that those HSOP Shares (or any HSOP Assets replacing such shares) allocated to the Partner With Unallocated Asset Share do not necessarily have to form part of the
relevant transaction) are sold or otherwise disposed of in the relevant Change of Control for consideration and the consideration from the relevant Change of Control is distributed by the Partnership to the relevant Partners and/or
(ii) proceeds received by the Company from the Change of Control are distributed by the Company to its shareholders (including the Partnership) and the relevant proceeds received by the Partnership are distributed by the Partnership to the
relevant Partners. 

  

	 	  	 “Change of Control” means the occurrence of any of the following events: (i)(A) any
consolidation or merger of the Company with or into any other corporation or other entity or person, or any other corporate reorganization, other than any such consolidation, merger or reorganization in which the stockholders of the Company
immediately prior to such consolidation, merger or reorganization, continue to hold at least a majority of the voting power of the surviving entity (or if the surviving entity is a wholly owned subsidiary, its parent) immediately after such
consolidation, merger or reorganization; or (B) any transaction or series of related transactions to which the Company is a party in which in excess of fifty percent (50%) of the Company’s voting power is transferred, other than any such
transfer in which the stockholders of the Company immediately prior to such transfer continue to hold at least a majority of the voting power of the surviving entity immediately after such transfer (each of (A) and (B) an
“Acquisition”); provided, that an Acquisition shall not include any transaction or series of transactions principally for bona fide equity financing purposes in which cash is received by the Company or any successor or indebtedness
of the Company is cancelled or converted into capital stock, or any combination thereof, or (ii) a sale, lease, exclusive license or other disposition of all or substantially all of the assets or intellectual property of the Company.

  

	 	b)	 The distribution of liquidation proceeds by the Company and the distribution of such proceeds by the
Partnership to the relevant Partners. 

  
 - 12 - 

	 	c)	 The implementation of a Listing and expiry of the period, if any, during which any transfer restrictions apply
regarding the shares in the Company (or any shares replacing such shares) due to the implementation of the Listing, regardless of whether such transfer restrictions follow from the applicable law, the regulations of the respective stock exchange
and/or market segment, or the regulations or recommendations of the underwriting bank (“Lock-Up Period”) as well as the issue or receipt, respectively, of a Distribution Request (as defined
below) by the relevant Partner With Asset Share. 

 No Re-Allocation Compensation
Amount shall be payable in the event that the relevant Partner With Asset Share ceases to be a Partner pursuant to section 7.1. Furthermore, no Re-Allocation Compensation Amount shall be payable with
regard to the reduction amount pursuant to section 7.2, if any, of the absolute amount of the HSOP Assets of the relevant Partner With Asset Share. 

It is herewith clarified that the Cash Compensation Amounts shall not exceed the amount of the proceeds (cash equivalent, as the case may be)
to be received by the relevant Partner from the Partnership in connection with the relevant Liquidity Event, whereas in case of lit. c) the market value of the relevant HSOP Shares distributed to the relevant Partner, as the case may be, shall
be decisive. 
  

	6.5	 The Partners shall be entitled to any monetary rights under this Agreement pro rata to the absolute amounts of
the relevant Partners’ HSOP Assets (including, for clarification purposes, the Partner With Unallocated Asset Share, to whom such HSOP Assets shall be allocated that are not allocated to other Partners With Assets Share from time to time, as
the case may be) inter se (in particular the participation in the profit and loss of the Partnership), except as expressly set forth otherwise in this Agreement and, for clarification purposes, except for the Cash Compensation Amounts that are
exclusively allocated to the Partner With Unallocated Asset Share. 

  

	7.	 Reverse vesting of participation in the Partnership 

 

	7.1	 A Partner With Asset Share, except for the Partner With Unallocated Asset Share, shall cease to be a partner
(Gesellschafter) of the Partnership immediately effective upon occurrence of a Bad Leaver Event (as defined in below). The Partner With Asset Share so ceasing to be a partner of the Partnership shall receive a compensation payment from the
Partnership. The Euro amount of such compensation shall be equal to the absolute amount of the relevant Partner’s HSOP Assets (i.e. the compensation shall be equal to the (notional) nominal value of the HSOP Shares allocated to the relevant
Partner With Asset Share). Such compensation shall be the sole compensation the relevant Partner With Asset Share shall receive under this Partnership Agreement and any and all other rights under or in connection with this Partnership Agreement
shall forfeit with the relevant Partner With Asset Share so ceasing to be a partner (Gesellschafter) of the Partnership. 

  
 - 13 - 

 “Bad Leaver Event” shall mean receipt by the relevant Partner With Asset
Share or the relevant individual holding all of the shares in the relevant Partner With Asset Share, respectively, of a notice of termination of the consultancy, employment and/or service relationship of the relevant Partner With Asset Share or the
relevant individual holding all of the shares in the relevant Partner With Asset Share, respectively, with the Company or an Affiliate, respectively, such termination to be declared by the Company/Affiliate due to dismissal on personal grounds or on
grounds of conduct for cause within the meaning of Sec. 626 German Civil Code (wichtiger Grund gemäß § 626 BGB), provided, however, that only the following personal grounds or
grounds of conduct shall constitute cause within the meaning of Sec. 626 German Civil Code under this section: (i) fraud, embezzlement, theft or any other material violation of law that occurs during or in the course of the consultancy,
employment and/or service relationship with the Company or relevant Affiliate, respectively; (ii) intentional or grossly negligent damage to any of the assets of the Company or relevant Affiliate, respectively; (iii) intentional or grossly
negligent disclosure of any of the confidential information of the Company or relevant Affiliate, respectively, contrary to applicable policies, consultancy agreement, employment agreement and/or service agreement; (iv) breach of material
obligations, or persistent breach of obligations, under the applicable consultancy agreement, employment agreement and/or service agreement; (v) intentional engagement in any competitive activity which would constitute a breach of the duty of
loyalty and/or of the obligations under the applicable consultancy agreement, employment agreement and/or service agreement; (vi) intentional or grossly negligent breach of any of the policies of the Company or relevant Affiliate, respectively;
(vii) the wilful and continued failure to substantially perform contractual duties for the Company or relevant Affiliate, respectively (other than as a result of incapacity due to physical or mental illness); or (viii) wilful conduct that
is demonstrably and materially injurious to the Company or relevant Affiliate, respectively, monetarily or otherwise, provided that any failure to meet performance standards or objectives as such, shall not be deemed to constitute “cause”.

 Affiliate” shall mean (i) any entity that, directly or indirectly, is controlling, controlled by or under the common
control of the Company, whereas “control” means the ability of such controlling person or entity to determine the affairs of another entity by way of (x) holding shares (y) possession of voting rights, or (z) any other way
whatsoever, and (ii) any other entity which the Company determines should be treated as an Affiliate. 
  

	7.2	 Notwithstanding section 7.1, the absolute amount of the HSOP Assets allocated to a Partner With Asset Share,
other than the Partner With Unallocated Asset Share, shall be deemed reduced immediately effective upon occurrence of a Good Leaver Event (as defined below), whereas the reduction amount shall be equal to the product of (i) absolute amount of
the HSOP Assets allocated to the relevant Partner With Asset Share, multiplied by (ii) the result of 1 minus 1/48 for each full calendar month which 

  
 - 14 - 

	 	
has lapsed from the date the relevant Partner With Asset Share has become a partner of the Partnership until the effective date of the Good Leaver Event, provided, however, that a cliff period of
12 (twelve) months shall apply; i.e. for all cases where the result calculated pursuant to preceding no. (ii) is higher than 0.75, the value pursuant to preceding no. (ii) shall be deemed to be 1.00 to the effect that all of the HSOP
Assets allocated to the relevant Partner With Asset Share will be forfeited and the relevant Partner With Asset Share will cease to be a partner (Gesellschafter) of the Partnership. Should the result obtained by the calculation according to
sentence 1 be a fraction, general mathematical principles shall apply. The Partner With Asset Share whose HSOP Assets are reduced or who ceases to be a partner of the Partnership, respectively, pursuant to the provisions of the preceding
sentences shall receive a compensation payment from the Partnership. The Euro amount of such compensation shall be equal to the absolute amount of the reduction of the relevant Partner’s HSOP Assets (i.e. the compensation shall be equal to the
(notional) nominal value of the HSOP Shares allocated to the relevant Partner by which the relevant Partner’s HSOP Assets are reduced). Such compensation shall be the sole compensation the relevant Partner With Asset Share shall receive under
this Partnership Agreement with regard to the reduction of the relevant Partner’s HSOP Assets or the ceasing of the relevant Partner to be a partner of the Partnership pursuant to the provisions of the preceding sentences and any and all other
rights under or in connection with this Partnership Agreement shall forfeit with regard to the relevant HSOP Assets or the ceasing to be a partner (Gesellschafter) of the Partnership, respectively, of the relevant Partner With Asset Share.

 “Good Leaver Event” shall mean with regard to the relevant Partner With Asset Share any termination,
without replacement, of the consultancy, employment and/or service relationship of the relevant Partner With Asset Share or the relevant individual holding all of the shares in the relevant Partner With Asset Share, respectively, with the Company or
any Affiliate which does not qualify as a Bad Leaver Event and which is not made for reason of Disability (as defined below) or death of the relevant Partner With Asset Share or the relevant individual holding all of the shares in the relevant
Partner With Asset Share, respectively. 
 “Disability” shall mean occupational disability (Berufsunfähigkeit)
according to Section 240 para. (2) of Volume IV of the Social Insurance Code (§ 20 Abs. 2 SGB VI) of a Partner With Asset Share or the relevant individual holding all of the shares in the relevant Partner With Asset Share,
respectively. Any costs related to the determination of Disability, in particular costs for examination, shall be borne by the Company. 
  

	7.3	 Each of a Good Leaver Event and a Bad Leaver Event shall only be relevant for the purposes of this section 7 if
having occurred at any time prior to the lapse of a period of four (4) years (“Vesting Period”) following (i) the date the relevant Partner With Asset Share has become a partner of the Partnership, or (ii) any other
date as agreed among the Partnership and the relevant Partner With Asset Share as “Vesting Start Date”, in particular in the Accession Agreement entered into with the relevant Partner With Asset Share. 

  
 - 15 - 

 Each of a Good Leaver Event and a Bad Leaver Event shall also be relevant if having occurred
prior to the relevant Partner With Asset Share’s accession to the Partnership, as the case may be (e.g., without limitation, in the period between the offer for accession to the Partnership and acceptance of such offer). 

 

	7.4	 In case Disability or death of the Partner With Asset Share or the relevant individual holding all of the
shares in the relevant Partner With Asset Share, respectively, occur prior to the expiration of the Vesting Period and, for the avoidance of doubt, no Bad Leaver Event or Good Leaver Event has occurred, then sections 7.1 and 7.2 shall no longer
apply. 

  

	7.5	 In the event that a Partner With Asset Share ceases to be a partner or the absolute amount of the HSOP Assets
of a Partner With Asset Share is reduced pursuant to this section 7, then the absolute amount of the HSOP Assets no longer attributed to the relevant Partner With Asset Share shall be attributed to the Partner With Unallocated Asset Share and the
absolute amount of the HSOP Assets of the Partner With Unallocated Asset Share shall be deemed increased accordingly. It is envisaged (for clarification: without establishing a binding obligation to that effect) that, in the short term (i.e. within
a period not longer than one (1) year), the amount of such increase of the absolute amount of the HSOP Assets of the Partner With Unallocated Asset Share is re-allocated to other/new Partners With Asset
Share. 

  

	7.6	 The amount of the relevant compensation payments (i.e. amounts equal to the (notional) nominal values of the
indirectly transferred HSOP Shares) referred to in sections 7.1 and 7.2 shall be paid by the Partnership to the affected Partner With Asset Share and advanced to the Partnership by the relevant other Partners with Asset Share (excluding the Partner
With Unallocated Asset Share) pro rata to their absolute amount of HSOP Assets inter se, irrespective of the fact that the relevant HSOP Assets will be exclusively re-allocated to the Partner
With Unallocated Asset Share. The amounts received by the Partnership from a later re-allocation of the relevant HSOP Assets from the Partner With Unallocated Asset Share to (a) Partner(s) With Asset
Share (i.e. amounts equal to the relevant (notional) nominal values of the relevant indirectly transferred HSOP Shares) shall be used to settle the amounts advanced by the Partners With Asset Share pursuant to the preceding sentence.

  

	7.7	 In order to give effect to the provisions of this section 7, distributions shall only be made to a Partner With
Asset Share in case of the following events to the following extent (the relevant part of the HSOP Assets distributable, from time to time, pursuant to this section 7.7, the relevant Partner’s “Vested HSOP Assets”):

  

	 	7.7.1	 After a liquidation of the Company all of the relevant HSOP Assets allocated to the relevant Partner With Asset
Share. 

  
 - 16 - 

	 	7.7.2	 In case of a Listing having occurred (i) only after the lapse of 1/4 of the Vesting Period (cliff period)
or occurrence of a Good Leaver Event, Disability or death of the relevant Partner With Asset Share or the relevant individual holding all of the shares in the relevant Partner With Asset Share and (ii) only to the extent the relevant HSOP
Assets allocated to the relevant Partner With Asset Share would not be forfeited, from time to time, pursuant to section 7.2 in case of occurrence of a Good Leaver Event (i.e. only to the extent the relevant HSOP Assets are vested).

  

	 	7.7.3	 In all other cases only after (i) occurrence of a Good Leaver Event and then only to the extent the
relevant HSOP Assets allocated to the relevant Partner With Asset Share are not be forfeited pursuant to section 7.2 (i.e. only to the extent the relevant HSOP Assets are vested), or (ii) the lapse of the Vesting Period or the occurrence of
Disability or death of the relevant Partner With Asset Share or the relevant individual holding all of the shares in the relevant Partner With Asset Share, respectively, and then all of the relevant HSOP Assets allocated to the relevant Partner With
Asset Share. 

 Section 8 shall remain unaffected. 

 

	8.	 Partner Accounts 

 

	8.1	 The Partnership shall maintain a capital account for each Partner (the “Partner Account(s)”)
except for the Partner Without Asset Share. 

  

	8.2	 The deposits, profit shares, loss shares, withdrawals, interest and other payment transactions between the
Partnership and each Partner shall be recorded on the Partner Account of the relevant Partner, with the exception of the deposits to be made in accordance with section 4 and except as expressly set forth otherwise in this Agreement. The Partner
Accounts are non-interest-bearing. 

  

	8.3	 No distributions or withdrawals shall be made from the Partner Accounts or otherwise to the Partners except in
case of dissolution of the Partnership or upon unanimous vote by all Partners. Notwithstanding the preceding sentence, 

  

	 	8.3.1	 any Cash Compensation Amounts shall be distributed to the Partner With Unallocated Asset Share within one
(1) week after receipt of the relevant amount by the Partnership, 

  

	 	8.3.2	 Any HSOP Assets held after the occurrence, or received in connection with, a Liquidity Event pursuant to
section 6.4.4 lit. a) (Change of Control) or lit. b) (Liquidation), that are then allocated to a Partner With Asset Share shall be distributed to a relevant Partner With Asset Share upon request to be issued at least in Textform towards the
Partnership, c/o the Managing Partner. For the avoidance of any doubt: The other provisions of this Agreement, in particular section 7.7, shall apply. 

  
 - 17 - 

	 	8.3.3	 Any HSOP Assets held after the occurrence, or received in connection with, a Liquidity Event pursuant to
section 6.4.4 lit. c) (Listing) shall be distributed in accordance with section 11. 

  

	9.	 Management, Representation 

 

	9.1	 In principle, the Partners shall manage and represent the Partnership jointly. In addition, to
facilitate the management and the representation of the Partnership, the Partnership shall have one managing Partner (the “Managing Partner”). The Managing Partner shall be authorized to solely manage and represent the Partnership
(allein geschäftsführungs- und vertretungsbefugt) within the Purpose. The Managing Partner shall be authorized to grant sub-powers of attorney and shall be fully
released from the restrictions of section 181 German Civil Code. In order to facilitate the representation of the Partnership in accordance with the provisions of this section 9 and the other provisions of this Agreement, the Partners shall
grant and maintain a separate power of attorney to the Managing Partner in the form as attached hereto as Annex 9.1 that shall without any further action being required automatically be newly granted
from time to time in case of changes in the group of partners. The power of attorney shall not expire upon the death of the relevant principals. 

The Managing Partner shall be authorized to represent the Partnership and all of its Partners with regard to the following transactions and
measures: 
  

	 	9.1.1	 any disposal of or other disposition over the Partnership Assets, in particular the shares in the Company held
by the Partnership (including in particular, but without limitation, the conclusion and execution of share sale and transfer agreements), in the event and to the extent that, under the Company’s Articles or any shareholders’ agreement
relating to the Company, as the case may be, (i) the Partnership is obliged to the relevant disposal or other disposition, and/or (ii) the relevant disposal or other disposition has been requested from the Partnership unless such request
is obviously unlawful or obviously contrary to the relevant agreement (offensichtlich vertragswidrig); 

  

	 	9.1.2	 accession of new partners to the Partnership and agreement on the terms and conditions of such accession (in
particular agreement on re-allocation, to the relevant new partner(s), of an amount of HSOP Assets then allocated to the Partner With Unallocated Asset Share (i.e.
re-allocation, to the relevant new partner(s), of an absolute number of HSOP Shares then allocated to the Partner With Unallocated Asset Share)) including by way of the entering into a respective accession
agreement (in particular in the form as attached hereto as Annex 9.1.2) and the subscription of respective HSOP Shares in the Company, provided, that the Company has in each case approved such accession as well as the relevant terms of
accession, and provided further, that, for the 

  
 - 18 - 

	 	
avoidance of any doubt, section 6.4 shall remain unaffected and apply. Notwithstanding the foregoing, each of the other Partners, that are partners of the Partnership from time to time,
herewith approves accession of new partners to the Partnership and subscription of HSOP Shares pursuant to this section 9.1.2 and and the Managing Partner’s authorization to effect such accession and subscription of HSOP Shares with the
approval of the Company, including agreement on the relevant terms of accession by way of entering into an accession agreement in the form as attached hereto as Annex 9.1.2; 

 

	 	9.1.3	 accession to, conclusion of new and/or amendment or cancellation of existing investment agreements and/or
shareholders’ agreements entered into with regard to the Company; 

  

	 	9.1.4	 any acts related to an initial public offering of the shares in the Company; in particular with regard to the
relevant stock exchange and/or the consortium banks responsible for the initial public offering; 

  

	 	9.1.5	 any and all acts and measures that are required to be taken to ensure compliance of the Partnership with the
provisions of the Company’s Articles and/or any other agreements entered into with regard to the Company (in particular, but without limitation, the exercise or waiver of any and all the rights attached to the shares in the Company (including
in shareholders’ meetings of Company)); 

  

	 	9.1.6	 filing of annual financial statements on behalf of the Partnership with the competent tax authorities,
assignment of accountants with the preparation of annual tax filings, if any. 

 The Managing Partner may incur liabilities
for and on behalf of the Partnership and/or with regard to the Partnership Assets only if and to the extent that such liabilities are inherent in this Agreement or any of the agreements referred to in section 9.1.3 or the relevant
agreement’s consummation. 
 Until resolved otherwise by the Partnership, the Managing Partner shall be the Partner Without Asset Share.
Prior to a Listing, the Partner Without Asset Share may only be removed as Managing Partner for cause and by unanimous Partner resolution (excluding the votes of the Partner Without Asset Share ). 

 

	9.2	 The Partnership may appoint one deputy managing Partner by unanimous Partner resolution. The deputy managing
Partner shall be responsible for the representation and the management of the Partnership in the event that no Managing Partner is appointed, or the Managing Partner is prevented from representing and/or managing the Partnership.

  

	9.3	 The Managing Partner and the deputy managing Partner, if any, shall be entitled to reimbursement of all
expenses in connection with the representation and the management of the Partnership upon provision of corresponding documentation; they shall not be entitled to compensation for the representation and the management of the Partnership.

  
 - 19 - 

	9.4	 The Managing Partner and the deputy managing Partner, if any, are entitled to resign from their position as
Managing Partner, respectively as deputy managing Partner on four weeks’ notice. The resignation declaration shall be addressed in writing to the Partner Without Asset Share, or in case of resignation by the Partner Without Asset Share to the
deputy managing Partner and/or the Partner With Unallocated Asset Share. 

  

	9.5	 To the extent legally permissible, the liability of the Managing Partner and the deputy managing Partner shall
be limited to gross negligence and wilful misconduct (grobe Fahrlässigkeit und Vorsatz). 

  

	10.	 Capital Measures at the Company 

 

	10.1	 In the event that the Partnership is entitled to any subscription rights due to an increase of the
Company’s share capital, any pre-emptive rights, rights of first refusal or similar rights, in particular, but without limitation, under a shareholders’ agreement or the Company’s Articles, the
partnership shall waive any such rights. Subscription rights with regard to HSOP Shares shall remain unaffected and may be exercised by the Managing Partner on behalf of the Partnership. 

 

	10.2	 In the event that the Partnership is entitled to any tag along right, the Partnership shall not exercise such
tag along right unless the Partners have resolved, with the majority pursuant to section 12.5, that the relevant tag along right shall be exercised with regard to all shares in the Company in respect of which the tag along right is exercisable. The
tag along right shall under no circumstances be exercised partially (e.g., no partial exercise with regard to the HSOP Shares allocated to (a) certain Partner(s) With Asset Share pursuant to this Agreement). 

 

	11.	 Listing 

In the event of a Listing, the following shall apply: 
  

	11.1	 Unless the Company’s Articles will continue to provide for the Secondary Rank Preference after the
Listing, each Partner With Asset Share, except for the Partner with Unallocated Asset Share, shall make a payment to the Partnership as a compensation for the discontinuation of the Secondary Rank Preference (the “Listing Compensation
Amount”). The Listing Compensation Amount shall for each HSOP Share with a (notional) nominal value of EUR 1.00 allocated to the relevant Partner With Asset Share be an amount equal to the Strike Price plus the a (notional) nominal value of
EUR 1.00. The Listing Compensation Amount shall not be payable immediately but shall be deferred with bearing interest of 2 % p.a. (in words: 2 per cent per annum) until the time of the receipt of Vested HSOP Assets or proceeds (following
a sale of Vested HSOP Assets) in accordance with to section 11.2. 

  
 - 20 - 

 For clarification purposes: No Listing Compensation Amount shall be payable in the event
that the relevant Partner With Asset Share ceases to be a Partner pursuant to section 7.1. Furthermore, no Listing Compensation Amount shall be payable with regard to the reduction amount pursuant to section 7.2, if any. 

 

	11.2	 At any time after, with regard to the relevant Partner With Asset Share or the relevant individual holding all
of the shares in the relevant Partner With Asset Share, respectively, the lapse of 1/4 of the Vesting Period (cliff period) or occurrence of a Good Leaver Event, Disability or death, each of the Partnership (represented by the Managing Partner) and
the relevant Partner With Asset Share (or its heirs, as the case may be) may request once or several times from the relevant other party, at least in Textform, (each a “Distribution Request”) that the Partnership distributes the
Vested HSOP Assets (by way of transferring the relevant ‘vested’ HSOP Shares allocated to the relevant Partner With Asset Share) to such Partner With Asset Share, provided, however, that such distribution and transfer shall be subject to
receipt by the Partnership of any outstanding amount of any Cash Compensation Amounts owed by the relevant Partner With Asset Share. 

Instead of implementing a distribution of Vested HSOP Assets pursuant to the preceding sentence, the relevant Partner With Asset Share shall be
entitled to notify the Partnership, at least in Textform, together with his Distribution Request or within one (1) week upon receipt of Distribution Request from the Partnership, that the relevant Partner With Asset Share wishes that the
Partnership liquidates the relevant Vested HSOP Assets (i.e. sale of the relevant HSOP Shares on the stock market) on behalf of the relevant Partner With Asset Share and distributes any proceeds received from such sale less any outstanding amount of
the Cash Compensation Amounts to the relevant Partner With Asset Share. 
 The Partnership and the relevant Partner With Asset Share,
respectively, shall take all actions and measures and enter into any agreements, if any, required to implement the provisions of this Section 11.2 without undue delay. 

The relevant Partner With Asset Share shall cease to be a partner to the Partnership upon taking effect of the relevant transfer or
distribution of all HSOP Assets allocated to the relevant Partner With Asset Share from time to time. 
  

	12.	 Resolutions of the Partners 

 

	12.1	 Partner resolutions shall be passed in Partner meetings. Partner meetings shall be called by the Managing
Partner in Textform with at least one week’s notice. The notice of the meeting shall include the items on the agenda. In urgent cases a meeting may be called with a reasonable shorter notice period. The notice period begins to run on the day
following the sending of the notice. The date of the meeting shall not be included in the calculation of the notice period. Partner meetings shall be held at the place of business of the Partnership. The Managing Partner shall chair the Partner
Meetings. 

  
 - 21 - 

	12.2	 The Managing Partner shall convene a Partner meeting 

 

	 	12.2.1	 in the cases required by law or by this Agreement; 

 

	 	12.2.2	 if the interests of the Partnership require the holding of a Partner meeting; 

 

	 	12.2.3	 if Partners holding individually or jointly at least one third (1/3) of the aggregate absolute amount of the
HSOP Assets or if the Partner Without Asset Share requests that a Partner meeting is held. 

  

	12.3	 In the event that all Partners participate in the passing of the relevant resolutions, Partner resolutions may
also be passed without complying with the notice and form requirements for the calling of a Partner meeting and also be passed in writing, by telefax, by e-mail or by other means of data transmission.

  

	12.4	 Partners meetings shall have a quorum if at least the Partner Without Asset Share and Partners holding (by
allocation) individually or jointly at least half (1/2) the aggregate absolute amount of the HSOP Assets are present or represented. If a Partner meeting does not have a quorum although properly convened, a new Partner meeting with the same agenda
shall be convened without delay thereby complying with all form and notice requirements. This subsequent Partner meeting shall have a quorum without regard to the number of votes present or represented provided this has been pointed out in the
convocation notice of the meeting. 

  

	12.5	 Subject to section 12.6, resolutions of the Partners shall be passed with a simple majority of the votes cast
including the consenting vote of the Partner Without Asset Share, provided that no other provisions of mandatory law or this Agreement require a higher majority for the relevant resolution. Each Partner, including the Partner Without Asset Share
shall have one vote. In the event of a tied vote, the proposed resolution shall be deemed to be rejected. In the adoption of Partner resolutions, each Partner may be represented by another partner or by a person bound by law to a professional
obligation to maintain confidentiality, provided that a written power of attorney is provided whereby submission by telefax or email attachment shall be sufficient. Furthermore, each Partner may be accompanied by a person bound by law to a
professional obligation to maintain confidentiality. 

  

	12.6	 Resolutions on any changes of this Agreement shall require the consent of all Partners. This also applies to
the Partners resolutions related to the exclusion of Partners in which case the excluded Partner shall not be entitled to vote. 

  

	12.7	 Decisions on the following items are reserved to the Partners who shall decide by way of Partner resolution:

  

	 	12.7.1	 Approval of the annual financial statements of the Partnership, if any; 

  
 - 22 - 

	 	12.7.2	 appointment and removal of the Managing Partner; 

 

	 	12.7.3	 granting of discharge to the Managing Partner; 

 

	 	12.7.4	 exclusion of Partners; 

 

	 	12.7.5	 items which are reserved to the Partners by mandatory law. 

 

	13.	 Confidentiality obligation 

The Partners have a duty to maintain strictly confidential
vis-à-vis third parties all confidential information and secrets of the Partnership, the Company and any and all entities affiliated with the Company
within the meaning of section 15 German Stock Corporation Act (AktG), in particular business and trade secrets, as far as they are not required to make disclosure on the basis of binding statutory provisions. This duty of confidentiality
also continues after termination of the status as Partner. 
  

	14.	 Distribution of profits and losses, withdrawals 

 

	14.1	 All income and expenses of the Partnership shall be continuously accounted for. Furthermore, all receipts shall
be kept separately. 

  

	14.2	 To determine the annual result, a revenue and expenditure account shall be drawn up as a surplus account
(Überschussrechnung) by the Managing Partner, unless required otherwise by law, and provided to the other Partners. The other Partners may file objections only within a period of one month after having been provided with the relevant
account. 

  

	14.3	 Profits and losses of the Partnership shall be attributed to the Partners applying Section 18.2 mutatis
mutandis. 

  

	14.4	 The profits or losses shall be credited to the relevant Partner Accounts of the Partners. For the avoidance of
any doubt: Section 8.3 shall apply with regard to any distributions to, or withdrawals by, the Partners. 

  

	14.5	 The Managing Partner shall prepare a separate and uniform profit statement (gesonderte und einheitliche
Gewinnfeststellung) for tax purposes. The Partners shall have the right to submit their costs associated with the Partnership (Sonderbetriebsausgaben) to the Managing Partner at the latest within two weeks after having been asked by the
Managing Partner to do so. In the event and to the extent that the Partners have not submitted their relevant costs to the Managing Partner within such two weeks’ period, it shall be deemed that the Partners do not have relevant costs. The
Managing Partner has the right to fully or partially refuse to consider costs associated with the Partnership of a Partner if the Managing Partner has reason to believe that the relevant costs are not or not fully associated with the Partnership.

  
 - 23 - 

	15.	 Disposal of participation in the Partnership 

 

	15.1	 The Partners may not sell and/or transfer of their participation in the Partnership or parts thereof without
the prior written consent of the Company and the Managing Partner. Without such consent any such sales or transfers shall not be valid. This shall apply accordingly with regard to other dispositions over the participation in the Partnership or of
parts thereof, in particular disposals without compensation, the conclusion of trust agreements (Treuhandvereinbarungen, treuhänderische Verfügungen), pledges or other encumbrances and the granting or
change of sub-participations or a right of use (Nießbrauch) as well as the granting of options or other contractual rights of third parties to the Partnership. 

 

	15.2	 Section 15.1 shall apply mutatis mutandis to any transfer of the economic interest or benefit of the
participation in the Partnership, e.g., by way of trusts, sub-participations or similar legal arrangements, as well as to any encumbrance of the participation in the Partnership or other disposition
(Verfügung). 

  

	16.	 Exclusion of Partners With Asset Share 

A Partner With Asset Share shall cease to be a partner of the Partnership without any further actions by the other Partners or the Partnership
being required: 
  

	16.1	 If the assets of the relevant Partner With Asset Share are the subject of insolvency proceedings or if the
assets of the relevant Partner With Asset Share are the subject of a refusal to open insolvency proceedings for lack of assets, effective on the day on which the insolvency proceedings are opened or the resolution refusing to open insolvency
proceedings for lack of assets is passed; 

  

	16.2	 if a creditor of the relevant Partner With Asset Share, on the basis of a title which is not only provisionally
enforceable, enforces the execution of the participation in the Partnership or claims of the Partner With Asset Share against the Partnership and the enforcement measure is not revoked within two months, at the latest until the liquidation of the
participation in the Partnership; 

  

	16.3	 if the relevant Partner With Asset Share’s interest in the Partnership Assets is seized by a private
creditor; 

  

	16.4	 in case of a Bad Leaver Event pursuant to section 7.1 occurring with regard to the relevant Partner With Asset
Share; 

  

	16.5	 in case of any violation of the provisions of section 15 and/or 20.2; 

 

	16.6	 if a serious cause within the meaning of section 133 Commercial Code (HGB) relating to the relevant
Partner With Asset Share is determined in a legally final manner or acknowledged by the relevant Partner With Asset Share. 

  
 - 24 - 

	17.	 Death of a Partner 

The participation in the Partnership can be inherited. In the event that the participation in the Partnership of a deceased Partner is
inherited by several persons jointly (e.g. by a community of heirs (Erbengemeinschaft)), the heirs shall be obliged to appoint a joint representative who shall exercise their rights arising from the participation in the Partnership. As long
as no joint representative is appointed, the rights from the participation in the Partnership shall be suspended. 
  

	18.	 Dissolution 

  

	18.1	 The Partners shall vote in favour of a dissolution of the Partnership as of the end of the fiscal year in which
all of the shares in the Company then held by the Partnership are being sold and transferred or otherwise disposed of, provided that (i) there are no underlying obligations of the Partnership towards the Company, the shareholders of the Company
or other parties (in particular the acquirer(s) of the shares), as a result of the sale and transfer of the shares in the Company and (ii) all of the relevant proceeds to be received by the Partnership in the course of the sale and/or transfer
of the shares in the Company, if any, have been in paid in cash. In the event that the conditions pursuant to no. (i) and or no. (ii) of the preceding sentence are not met, any cash amount, if any, of the proceeds received by the
Partnership shall be allocated to the Partners in accordance with section 14.3 and subsequently distributed to the relevant Partners. 

  

	18.2	 If the Partnership is dissolved, the assets shall be distributed to the Partners thereby tracking the financial
return of the Partnership on the relevant HSOP Shares. Therefore, in the event and to the extent that the assets of the Partnership pertain to particular HSOP Shares (e.g., as sales proceeds, dividend payments or similar payments), such
assets shall be distributed to the relevant Partners to whom such HSOP Shares are allocated in section 6.3. Otherwise, the HSOP shall, as a general rule, be distributed as among the Partners pro rata to the absolute amounts of their HSOP Assets
inter se and the Cash Compensation Amounts shall be distributed to the Partner with Unallocated Asset Share exclusively. 

  

	18.3	 Each Partner With Asset Share, except for the Partner With Unallocated Asset Share, agrees to pay to the
Partnership any debit balance on the Partner Account. Until receipt of such payments, the Managing Partner shall be entitled and obliged to refuse distributions or payment to the relevant Partner. As long as a Partner has not fully complied with his
obligations under section 19 of this Agreement as well as any duties or obligations arising as a result of a sale of the HSOP Shares (e.g. lockup periods resulting from an applicable stock exchange, listing regulation or agreements made with a
consortium of banks, or hold back provisions for indemnification purposes), the Managing Partner shall be entitled and obliged to refuse distributions or payment to the relevant Partner. 

  
 - 25 - 

	18.4	 In case the compensation in a Liquidity Event is being paid in shares of an acquiring entity in full or in
part, the Managing Partner may decide in his sole discretion as to whether the Partnership shall continue with regard to the share portion of such Liquidity Event or if the share portion shall be distributed to the Partners. 

 

	18.5	 Any consequences regarding taxes, including potential withholding taxes, triggered by the Liquidity Event shall
be taken into consideration by the Managing Partner when making any distributions to the Partners. 

  

	19.	 Taxes 

All taxes payable by the Partners in connection with the granting of a participation in the Partnership, during the participation in the
Partnership and upon distribution of the Partnership Assets on dissolution shall be borne by the relevant Partners themselves. As far as required by law, the Company or its affiliated companies shall deduct these taxes and charges from relevant
payments to the Partner and transfer it to the responsible tax authority. As far as this amount which is deducted is not sufficient to pay the taxes and public charges, the Partners are required respectively by way of a contract in favour of a third
party (echter Vertrag zugunsten Dritter) to pay to the Company or the relevant entity affiliated with the Company the amount of any difference of the entire debt relating to such taxes or charges within one calendar week after receipt of a
relevant request. In the event and to the extent that the responsible tax authority subsequently sets a higher tax, the relevant Partner shall be required to pay the additional amount of the relevant taxes and other charges to the tax authority also
by way of a contract in favour of a third party (echter Vertrag zugunsten Dritter) to release the Company or the relevant entity affiliated with the Company from their relevant liability. The related tax risk and risk of public charges to be
paid shall be borne by the relevant Partner. The provisions of this section shall continue to apply after a Partner has ceased the Partnership and after the termination of the Partnership. 

 

	20.	 Final Provisions 

 

	20.1	 The Partners are aware of the Company’s Articles. Each Partner confirms vis-à-vis the relevant other Partners that he agrees to the provisions of the Company’s Articles as a whole and recognizes that these are binding, also in the event of a future distribution of the
Partnership Assets upon dissolution. 

  

	20.2	 Except as expressly provided otherwise in this Agreement, any assignment of rights and/or obligations resulting
from or in connection with this Agreement requires the prior written consent of all of the other Partners. 

  
 - 26 - 

	20.3	 Except as expressly provided otherwise in this Agreement, no Partner shall be entitled to set-off (aufrechnen) or net-off (verrechnen) against any claims of any other Partner under or in connection with this Agreement or to exercise any right of
retention (Zurückbehaltungsrecht). 

  

	20.4	 In this Agreement, the headings are inserted for convenience only and shall not affect the interpretation of
this Agreement. 

  

	20.5	 Unless the context otherwise requires (i) the terms “including” and “in particular”
shall always mean “including, without limitation” and “in particular, without limitation”, respectively; (ii) references to the singular shall include the plural and vice versa and (iii) references to a gender include
any other gender. 

  

	20.6	 Where a German term has been inserted in quotation marks and/or italics it alone (and not the English term to
which it relates) shall be authoritative for the purpose of the interpretation of the relevant English term in this Agreement. 

  

	20.7	 Changes and supplements of this Agreement must be made at least in writing to be valid. This also applies for a
waiver of the writing requirement. 

  

	20.8	 If individual provisions of this Agreement are or become invalid or unenforceable, or this Agreement contains
gaps, this shall not affect the validity of the remaining provisions of this Agreement. In place of the invalid, unenforceable or missing provisions, the Partners agree to enter into reasonable provisions which correspond to the intention of the
Partners as well as the purpose of this Agreement as far as the Partners would have considered this upon conclusion of this Agreement. If a provision of this Agreement should be or become invalid due to the scope or time of performance agreed on
therein, the scope of performance or the agreed time of performance shall be adjusted to the legally admissible scope. 

  

	20.9	 This Agreement shall be governed by the laws of the Federal Republic of Germany save for its conflict of laws
provision and the Convention on the International Sale of Goods (CISG). 

  

	20.10	 To the extent legally permissible, the exclusive venue for all disputes arising from this Agreement shall be
Munich, Germany. 

  

					
	_______________, ___. ___. 2020	 		 	_______________, ___. ___. 2020
			
	 /s/ Florian Brand
	 		 	          

	Florian Brand	 		 	ATAI Life Sciences AG
		 		 	Represented by: _______________
		 		 	Position: _____________________

  
 - 27 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]